Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504
Evaluation completed of first dose level in investigator-sponsored study in biochemically recurrent prostate cancer Enrollment initiated for second dose...
Stay updated with breaking news from Advaxis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Evaluation completed of first dose level in investigator-sponsored study in biochemically recurrent prostate cancer Enrollment initiated for second dose...
Stock Analysts’ new coverage for Friday, June 17th: StockNews.com began coverage on shares of Altisource Asset Management (NYSE:AAMC). StockNews.com issued a hold rating on the stock. StockNews.com assumed coverage on shares of Almaden Minerals (NYSE:AAU). The firm issued a sell rating on the stock. BMO Capital Markets began coverage on shares of Adobe (NASDAQ:ADBE). The […]
Investment Analysts’ new coverage for Thursday, June 9th: StockNews.com assumed coverage on shares of Altisource Asset Management (NYSE:AAMC). The firm issued a hold rating on the stock. StockNews.com assumed coverage on shares of Almaden Minerals (NYSE:AAU). The firm issued a sell rating on the stock. StockNews.com started coverage on shares of Acme United (NYSE:ACU). They […]
Announced Publication of ADXS-PSA Data in The Oncologist Presented Updated Clinical and Immunogenicity Data from Ongoing Phase 1/2 Trial of ADXS-503 in...
Analysts’ new coverage for Tuesday, May 31st: The Goldman Sachs Group, Inc. initiated coverage on shares of ABN AMRO Bank (OTCMKTS:AAVMY). The firm issued a neutral rating and a €13.25 ($14.25) price target on the stock. StockNews.com began coverage on shares of Acme United (NYSE:ACU). StockNews.com issued a hold rating on the stock. Berenberg Bank […]